Laboratory monitoring for adverse effects of ART
This guideline was developed by the New York State Department of Health AIDS Institute to establish an evidence-based approach to routine laboratory monitoring of antiretroviral toxicity. Data are lacking regarding the need for and frequency of routine laboratory monitoring in patients receiving ant...
| Main Author: | |
|---|---|
| Corporate Authors: | , |
| Format: | eBook |
| Language: | English |
| Published: |
Baltimore (MD)
Johns Hopkins University
September 2019, 2019
|
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | This guideline was developed by the New York State Department of Health AIDS Institute to establish an evidence-based approach to routine laboratory monitoring of antiretroviral toxicity. Data are lacking regarding the need for and frequency of routine laboratory monitoring in patients receiving antiretroviral therapy (ART). To date, no randomized controlled studies have assessed the optimal type and frequency of monitoring. The data available are based on short-term randomized clinical trials of ART strategies, observational cohort data, and long-term epidemiologic data |
|---|---|
| Item Description: | At head of title: "Clinical Guidelines Program, New York State, Department of Health, AIDS Institute." |
| Physical Description: | 1 PDF file (6 pages) |